ArticleBriefings in bioinformatics2025
MODA: a graph convolutional network-based multi-omics integration framework for unraveling hub molecules and disease mechanisms.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Advances in omics technologies provide unprecedented opportunities for systems biology, yet integrating multi-omics data remains challenging due to its complexity, heterogeneity, and the sparsity of prior knowledge networks. Here, we introduce a multi-omics data integration analysis (MODA) framework that fully incorporates prior knowledge to identify hub molecules and pathways, and elucidate biological mechanisms. By leveraging multiple machine learning approaches, MODA transforms raw omics data into a feature importance matrix that is mapped onto a biological knowledge graph to mitigate omics data noise. Then, it uses graph convolutional networks with attention mechanisms to capture intricate molecular relationships and rank molecules via a feature-selective layer. Ultimately, MODA transcends the limitations of predefined pathway annotations by employing an overlapping community detection algorithm to extract core functional modules that are involved in multiple pivotal disease pathways. Systematic evaluations show that MODA outperforms seven existing multi-omics integration methods in classification performance while maintaining biological interpretability. Moreover, MODA achieves superior stability in pan-cancer datasets. Application to the multi-omics datasets of prostate cancer reveals a key role for carnitine and palmitoylcarnitine, regulated by BBOX1 in the progression of prostate cancer. Population samples and in vitro experiments further validate these findings. With high data utilization efficiency and low computational cost, MODA serves as a robust tool for uncovering novel disease mechanisms and advancing precision medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.